Cargando...

Monitor tumor burden with circulating tumor DNA

There is a need to identify better biomarkers to monitor diseases and/or assess therapeutic responses. For those with cancer, one can identify DNA fragments that contain somatic mutations originating in the tumor DNA in plasma or serum. There have been several early studies suggesting that advances...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Figg II, William D, Reid, Jim
Formato: Artigo
Lenguaje:Inglês
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3841207/
https://ncbi.nlm.nih.gov/pubmed/23792566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.25361
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!